Signaling pathways
-
BA5209 GW-405833Summary: GW-405833 (L768242) is a potent and selective cannabinoid receptor 2 agonist. -
BA5210 TM38837Summary: 4 (TM38837) is an inverse agonist of cannabinoid receptor 1 is 0.4 nM. -
BA5211 VirodhamineSummary: Virodhamine is an endogenous cannabinoid that regulates neurotransmission by activating cannabinoid (CB) receptors. -
BA5213 TedalinabSummary: Tedalinab (GRC-10693) is a potent, orally active, selective cannabinoid receptor 2 agonist. -
BA5214 VicasinabinSummary: Vicasinabin (RG7774) is a potent agonist of cannabinoid receptor 2. -
BA5215 CB1-IN-1Summary: CB1-IN-1 (BPRCB1184) is a novel peripheral cannabinoid-1 receptor (CB1R) antagonist. -
BA5216 AZD1940Summary: AZD1940 is an orally active, high affinity cannabinoid receptor agonist. -
BA5217 GAT211Summary: GAT211 is a cannabinoid 1 receptor orthosteric modulator (PAM) with a pKb of 7.26. -
BA5218 S-777469Summary: S-777469 is a selective, orally active cannabinoid type 2 receptor agonist. -
BA5219 AM-6538Summary: AM6538 is a long-acting, high-affinity, pseudo-irreversible antagonist.
